Zobrazeno 1 - 10
of 59
pro vyhledávání: '"R, Gielen"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Barbara M Schulte, Paul R Gielen, Esther D Kers-Rebel, Gerty Schreibelt, Frank J M van Kuppeveld, Gosse J Adema
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121670 (2015)
Enteroviruses often cause mild disease, yet are also linked to development of autoimmune diabetes. Dendritic cells (DCs) shape both innate and adaptive immune responses, including anti-viral responses. How different human DC subsets shape anti-viral
Externí odkaz:
https://doaj.org/article/35a2a9f8783047cfac97ad5199af7ea2
Autor:
Gosse J. Adema, Pieter Wesseling, Sandra A. J. F. H. Bossman, Barbara M. Schulte, Paul R. Gielen, Mark ter Laan, Kim C. M. Santegoets, Christian Büll, Esther D. Kers-Rebel, Benno Küsters
Publikováno v:
Cancer Immunology, Immunotherapy, 68(6), 937-949. Springer Science and Business Media Deutschland GmbH
Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 68, 6, pp. 937-949
Santegoets, K C M, Gielen, P R, Büll, C, Schulte, B M, Kers-Rebel, E D, Küsters, B, Bossman, S A J F H, ter Laan, M, Wesseling, P & Adema, G J 2019, ' Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma ', Cancer Immunology, Immunotherapy, vol. 68, no. 6, pp. 937-949 . https://doi.org/10.1007/s00262-019-02332-w
Cancer Immunology Immunotherapy, 68, 937-949
Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 68, 6, pp. 937-949
Santegoets, K C M, Gielen, P R, Büll, C, Schulte, B M, Kers-Rebel, E D, Küsters, B, Bossman, S A J F H, ter Laan, M, Wesseling, P & Adema, G J 2019, ' Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma ', Cancer Immunology, Immunotherapy, vol. 68, no. 6, pp. 937-949 . https://doi.org/10.1007/s00262-019-02332-w
Cancer Immunology Immunotherapy, 68, 937-949
Gliomas appear to be highly immunosuppressive tumors, with a strong myeloid component. This includes MDSCs, which are a heterogeneous, immature myeloid cell population expressing myeloid markers Siglec-3 (CD33) and CD11b and lacking markers of mature
Autor:
Paul R. Gielen, Jan W. A. Smit, Gosse J. Adema, Katrin Rabold, Romana T. Netea-Maier, Esther D. Kers-Rebel, Mihai G. Netea
Publikováno v:
Oncologist, 24, 3, pp. E106-E110
Oncologist, 24, E106-E110
Oncologist, 24, E106-E110
Background Aggressive forms of thyroid carcinoma (TC) show an abundant infiltration of immune cells, and this correlates with prognosis. However, little is known about circulating immune cell levels in advanced TC. Objective Investigate T-cell and my
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08988b1839e26f6015b36d3f5c5e5ee9
https://hdl.handle.net/2066/202146
https://hdl.handle.net/2066/202146
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katharina Lind, Barbara M. Schulte, Paul R. Gielen, Esther D. Kers-Rebel, Gosse J. Adema, Cees J. Tack, Lammy D. Elving, Amy Prosser, Malin Flodström-Tullberg
Publikováno v:
Viral Immunology, 29, 7, pp. 389-97
Viral Immunology, 29, 389-97
Viral Immunology, 29, 389-97
Contains fulltext : 172472.pdf (Publisher’s version ) (Closed access) In children at risk for type 1 diabetes, innate immune activity is detected before seroconversion. Enterovirus infections have been linked to diabetes development, and a polymorp
Autor:
Gosse J. Adema, Mark ter Laan, Pieter Wesseling, Sandra A. J. F. H. Bossman, Barbara M Schulte, Kiek Verrijp, Esther D. Kers-Rebel, Paul R Gielen
Publikováno v:
Gielen, P R, Schulte, B M, Kers-Rebel, E D, Verrijp, K, Bossman, S A J F H, Ter Laan, M, Wesseling, P & Adema, G J 2016, ' Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function ', Neuro-Oncology, vol. 18, no. 9, pp. 1253-64 . https://doi.org/10.1093/neuonc/now034
Neuro-Oncology, 18(9), 1253-64. Oxford University Press
Neuro-Oncology, 18, 9, pp. 1253-64
Neuro-Oncology, 18, 1253-64
Neuro-Oncology, 18(9), 1253. Oxford University Press
Neuro-Oncology, 18(9), 1253-64. Oxford University Press
Neuro-Oncology, 18, 9, pp. 1253-64
Neuro-Oncology, 18, 1253-64
Neuro-Oncology, 18(9), 1253. Oxford University Press
Contains fulltext : 167769.pdf (Publisher’s version ) (Closed access) BACKGROUND: Gliomas are primary brain tumors that are associated with a poor prognosis. The introduction of new treatment modalities (including immunotherapy) for these neoplasms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60090862d2b78c831cd7640746469450
https://doi.org/10.1093/neuonc/now034
https://doi.org/10.1093/neuonc/now034
Autor:
Paul R. Gielen, Melissa Wassink, Martijn H. den Brok, Peter M. Hoogerbrugge, Michiel Kroesen, Gosse J. Adema, Louis Boon, Inna Armandari, Christian Büll, Maaike W. G. Looman, Ingrid C. Brok
Publikováno v:
Oncoimmunology, 5, 6, pp. e1164919
Oncoimmunology
Oncoimmunology, 5, e1164919
Oncoimmunology
Oncoimmunology, 5, e1164919
Contains fulltext : 171471.pdf (Publisher’s version ) (Open Access) Neuroblastoma (NBL) is a childhood malignancy of the sympathetic nervous system. For high-risk NBL patients, the mortality rate is still over 50%, despite intensive multimodal trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8e017b29146e05d025c33cefba38d3
https://hdl.handle.net/2066/171471
https://hdl.handle.net/2066/171471
Autor:
Frank Padberg, H. Giesler, Harald Scherk, D. Geissler, Daniel Strech, Oliver Gruber, Peter Brieger, Tom Bschor, Peter Bräunig, R. Gielen, Peter Falkai, C. Muche-Borowski, Thomas C. Baghai, Michael Bauer, Thomas D. Meyer, Andrea Pfennig, K. H. Möhrmann, Ina Kopp
Publikováno v:
Der Nervenarzt. 83:568-586
Publikováno v:
Der Nervenarzt. 83:587-594
„Trialog“ meint die moglichst gleichberechtigte Zusammenarbeit von Betroffenen/Patienten und Behandlern sowie das selbstverstandliche Einbeziehen der Angehorigen. Das gilt fur die Therapie, die Antistigmaarbeit, bei der Planung der Versorgung, in